Achilles tendon repair with acellular tissue graft augmentation in neglected ruptures.

Achilles tendon repair with acellular tissue graft augmentation in neglected ruptures.
复制标题

DOI:
10.1053/j.jfas.2007.05.007
复制
发表时间:
2007-11-01
期刊:
The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons
影响因子:
--
通讯作者:
Lee, Daniel K
Lee, Daniel K
中科院分区:
其他
文献类型:
--
作者:
Lee, Daniel K

文献摘要

被引文献

相似文献

由于修复过程中肌腱组织的质量和数量以及施加在肌腱上的机械力的大小,被忽视的跟腱断裂损伤给手术带来了挑战。本研究的目的是评估脱细胞人体真皮组织基质 GRAFTJACKET 作为增强材料在被忽视的跟腱修复中的效果。对 9 名被忽视的跟腱断裂患者进行了评估并随访了至少 20 个月。初次修复后用移植物进行增强并围绕肌腱进行圆周缝合。患者接受早期功能康复计划,并在术后 3、6 和 12 个月进行评估。结果评分是根据美国骨科足踝协会踝-后足评分系统计算的。术后20至30个月的随访范围内,未出现再破裂或复发性疼痛的情况。平均恢复活动时间为 15.2 +/- 1.7 周。该回顾性临床系列的结果表明,使用脱细胞人体真皮组织基质来增强被忽视的跟腱断裂初步修复提供了理想的恢复活动时间点,并且比之前报道的手术方案提供了可行的手术替代方案。
Neglected Achilles tendon rupture injuries present surgical challenges because of the quality and quantity of tendon tissue during repair combined with the magnitude of mechanical forces placed on this tendon. The purpose of this study was to evaluate the effects of an acellular human dermal tissue matrix, GRAFTJACKET, as an augmentation material in neglected Achilles tendon repair. Nine patients with neglected Achilles tendon ruptures were evaluated and followed up for a minimum of 20 months. Primary repair was followed by augmentation with the graft and suturing circumferentially around the tendon. Patients were placed in an early, functional rehabilitation program with postoperative evaluation at 3, 6, and 12 months. Outcome scores were calculated based on the American Orthopaedic Foot and Ankle Society ankle-hindfoot scoring system. At 20 to 30 months postoperative follow-up range, there has been no incidence of re-rupture or recurrent pain. The average return-to-activity time was 15.2 +/- 1.7 weeks. The results from this retrospective clinical series suggest that using an acellular human dermal tissue matrix to augment neglected Achilles tendon rupture primary repair offers desirable return-to-activity time points and viable surgical alternative over previously reported surgical options.